Ausgabe 4/2023
Inhalt (8 Artikel)
A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C
Richard Kim, Alexis D. Leal, Aparna Parikh, David P. Ryan, Shining Wang, Brittany Bahamon, Neeraj Gupta, Aaron Moss, Joanna Pye, Harry Miao, Haig Inguilizian, James M. Cleary
Correction to: A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C
Richard Kim, Alexis D. Leal, Aparna Parikh, David P. Ryan, Shining Wang, Brittany Bahamon, Neeraj Gupta, Aaron Moss, Joanna Pye, Harry Miao, Haig Inguilizian, James M. Cleary
Emetine, a small molecule natural product, displays potent anti-gastric cancer activity via regulation of multiple signaling pathways
Xuerun Peng, Jianyou Shi, Zhipeng Zhao, Rongsheng Tong, Xiaonan Zhang, Lei Zhong
A prospective feasibility study of uracil–tegafur and leucovorin as adjuvant chemotherapy for patients aged ≥ 80 years after curative resection of colorectal cancer, the HiSCO-03 study
Hiroshi Okuda, Manabu Shimomura, Satoshi Ikeda, Masahiro Nakahara, Masashi Miguchi, Yasuyo Ishizaki, Yasuhumi Saitoh, Kazuhiro Toyota, Daisuke Sumitani, Yosuke Shimizu, Yuji Takakura, Wataru Shimizu, Masanori Yoshimitsu, Shinya Kodama, Masahiko Fujimori, Mamoru Oheda, Hironori Kobayashi, Hideki Ohdan
Olaparib in an ovarian cancer patient with end-stage renal disease and hemodialysis
Joanna Baum, Daniel Zickler, Juliane Bolbrinker, Rolf Richter, Elena Ioana Braicu, Jacek Grabowski, Jalid Sehouli
Impact of pre-hydration duration on high-dose methotrexate induced nephrotoxicity in childhood acute lymphoblastic leukaemia in resource constraint centers: a randomized crossover study
Sanjeev Khera, Deepti Mahajan, Kapil Barbind, Sandeep Dhingra
Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma
Laurence Legros, Alina Pascale, Catherine Guettier, Pirayeh Eftekhari, Yasmina Ben Merabet, Maryse Stang, Rachel Bossevot, Emma Goldschmidt, Ayhan Ulusakarya, Stephane Morisset, Maïté Lewin, Didier Samuel, Olivier Rosmorduc
A three-marker signature identifies senescence in human breast cancer exposed to neoadjuvant chemotherapy
Mohammed El-Sadoni, Sofian Al Shboul, Ahmad Alhesa, Nisreen Abu Shahin, Elham Alsharaiah, Mohammad A. Ismail, Nidaa A. Ababneh, Moureq R. Alotaibi, Bilal Azab, Tareq Saleh